The Rarified World Of High Finance

TEVA is based in Israel, but is publicly traded on America's stock markets. It has a Market Capital of $33 billion. All this company does is make generic drugs, which are drugs developed by another company, and are coming off their patents.

 

Take A Bottle Of Valium As An Example

They crank it out in a Mexican plant for 30 cents and an American pharmacy pays $12.00 for it.

 

But Here Is The Big Money

That company is worth $33 billion on the NASDAQ. And that $33 billion comes from your pension plans, and winds up in a Zionist bigwig's pocket.
 

Israel's Teva Buys US Copycat Drug Rival For $7.5bn

The global leader in copycat drug manufacture, Teva Pharmaceuticals, is taking over a US rival, Barr Pharmaceuticals, in a $7.5 billion deal which continues a rapid spate of consolidation in the crowded industry for generic medicines.

 

How Does This Come About?

The answer lies in the world of Sayanims. It is a world of Zionist inter-dependence, where a Starbucks outlet can get an exclusive toll road plaza, airport space, prime mall space, etc., but others can't get in the door.